Aphria Inc

What Aphria Inc does

Aphria Inc. is a Canadian licensed cannabis producer founded in 2013 and headquartered in Leamington, Ontario, that now operates as a wholly-owned subsidiary of Tilray Brands, Inc. (NASDAQ: TLRY) following an all-stock merger in 2021 valued at approximately $3.3 billion. The company produces and distributes pharmaceutical-grade medical cannabis and adult-use recreational cannabis products under a diversified brand portfolio that includes Aphria and Broken Coast for medical patients, and Broken Coast, Solei, Good Supply, Riff, and the PORTAL high-potency brand for recreational consumers. Operations are anchored by Health Canada Licensed cultivation and GMP-certified production facilities, with distribution reaching provincial cannabis stores across Canada as well as international medical markets via Tilray Deutschland GmbH in Germany.

The business operates two parallel go-to-market motions: a regulated medical channel serving registered patients who provide healthcare practitioner documentation and purchase through dedicated e-commerce platforms (aphria.ca, brokencoastrx.com), and an adult-use channel serving consumers through own-brand websites (brokencoast.com, solei.ca, goodsupplycannabis.com, whatisriff.ca) and provincial retailers. Revenue is generated primarily through unit-priced product sales in Canadian dollars with pay-as-you-go billing; the company does not disclose subscription or recurring revenue mechanics. Marketing relies on owned websites, social media presence across multiple platforms, email marketing, and event-driven launches tied to cannabis-observance dates. Recent strategic emphasis has been on premiumization through the PORTAL ultra-high-potency THC product line (40%+ pre-rolls, 95-99% THC vapes), and the portfolio has expanded beyond cannabis flower into adjacent verticals such as craft beverages via the SweetWater Brewing acquisition.

Name

Aphria Inc

Legal name

Aphria Inc.

Website

https://aphriainc.com

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Aphria Inc. is a Canadian Health Canada-licensed cannabis producer serving medical patients and adult recreational consumers through a multi-brand portfolio (Aphria, Broken Coast, Solei, Good Supply, Riff, PORTAL), now operating as a wholly-owned subsidiary of Tilray Brands (NASDAQ: TLRY) following a 2021 merger.

Ownership category

akta.pro rank

Product category

Cannabis Products

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Cannabis Dispensary + Delivery/Online Pickup (Omnichannel Retail) (CRANAFAG)

akta.pro secondary industry

Adult-Use (Recreational) Cannabis Delivery & Online Ordering (CRANAGAH)

Keywords

• Pharmaceutical-grade cannabis
• Medical cannabis products
• Recreational cannabis brands
• Cannabis cultivation production
• Cannabis e-commerce platforms

Headquarters

HQ city

Leamington

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Medical Cannabis Sales: Direct-to-patient sales through medical use websites (aphria.ca, brokencoastrx.com) where patients register and purchase cannabis products with medical documentation
2. Adult/Recreational Cannabis Sales: Product sales through recreational use websites (brokencoast.com, solei.ca, goodsupplycannabis.com, whatisriff.ca) and provincial cannabis retailers
3. High-Potency Cannabis Products: Premium cannabis products including PORTAL brand with ultra-high THC content targeting experienced consumers

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels4 records

Core offering

Aphria Inc cultivates, produces, and sells pharmaceutical-grade medical and recreational cannabis products under multiple brands within the Tilray portfolio. It operates direct-to-patient medical cannabis e-commerce platforms requiring healthcare practitioner registration, and distributes recreational cannabis products through its own consumer websites and provincial cannabis retailers across Canada.

Product overview

Aphria Inc operates as a subsidiary of Tilray Brands, functioning as a multi-brand cannabis company. The product portfolio includes medical cannabis platforms (Aphria.ca and Broken Coast Rx) where patients register with healthcare practitioner verification to purchase medical cannabis, alongside recreational cannabis brands (Broken Coast, Solei, Good Supply, and Riff) serving the adult-use consumer market. Content in Canadian communications relates to cannabis produced in accordance with Health Canada Licences by Aphria Inc.

Differentiator

Problem solved

Functional benefit

Products and services

• Aphria.ca Medical cannabis e-commerce platform operated within the Tilray Group, allowing registered patients and caregivers to register, submit medical documentation completed by a healthcare practitioner, and purchase prescription cannabis products with dosage information and insurance details.
• Broken Coast Rx Medical cannabis website operated by Tilray Brands, offering medical cannabis products to registered patients who complete the patient registration and medical documentation process.
• Broken Coast Adult-use recreational cannabis brand operated within the Tilray portfolio, sold directly to consumers through its website and through provincial cannabis retailers across Canada.
• Solei Adult-use recreational cannabis brand under the Tilray portfolio, including cannabis-infused beverages and products, sold through its consumer website and provincial retailers in Canada.
• Good Supply Adult-use recreational cannabis brand positioned as a value offering within the Tilray portfolio, sold through its consumer website and provincial cannabis retailers across Canada.
• Riff Adult-use recreational cannabis brand under the Tilray portfolio, sold through its consumer website and provincial retailers across Canada.
• PORTAL Premium high-potency cannabis brand within the Tilray portfolio featuring infused pre-rolls above 40% THC and vape cartridges with 95-99% THC content, targeting experienced recreational consumers.

Quantifiable outcome

• Analyst profitability prediction for current fiscal year following strong Q3 fiscal 2026 results
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators7 records

Recent moves5 records

Expansion highlights4 records

Emerging players

• Curaleaf Holdings: Large U.S. multi-state cannabis operator with branded flower, vapes, and concentrates — comparable in scale of branded cannabis distribution, with significant overlap in vape and concentrate categories where PORTAL competes.
• Trulieve Cannabis: Vertically integrated U.S. cannabis operator with branded medical and adult-use products across multiple state markets — comparable vertically integrated and multi-brand approach to Aphria.
• High Tide Inc. Canadian cannabis retailer with a growing proprietary consumer brand portfolio and accessory retail — overlaps with Aphria's recreational branded product distribution at the consumer-facing end of the value chain.
• Green Thumb Industries: U.S. multi-state cannabis operator with branded flower, vapes, and pre-rolls — comparable in branded product strategy though operating under U.S. (currently state-level) regulatory frameworks.

Direct peers

• OrganiGram Holdings: Canadian licensed producer competing in both medical and adult-use flower, pre-rolls, and vapes with provincial retail distribution — closely comparable in product mix and channel strategy to Aphria.
• Canopy Growth Corporation: One of the largest Canadian licensed producers of medical and recreational cannabis with multi-brand portfolios and international exposure — directly comparable in scale, channel mix, and product breadth to Aphria/Tilray.
• HEXO Corp: Canadian cannabis producer with adult-use and medical offerings distributed through provincial retailers — a direct peer in the Canadian recreational branded flower and pre-roll segment.
• Aurora Cannabis: Major Canadian cannabis producer with both medical (Aurora MD) and recreational brands plus EU GMP-certified production — a direct competitor in medical exports and Canadian retail distribution.
• Cronos Group: Canadian cannabis producer with medical and adult-use brands and international ambitions — competes with Aphria across recreational brands and cross-border medical exports.

Regional players

• Decibel Cannabis Company: Canadian-licensed producer focused on premium flower and pre-rolls distributed through provincial wholesalers — a regional/scale peer competing for the same premium recreational shelf space as the Aphria family of brands.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/aphriainc
• Facebookfacebook.com/aphriainc
• LinkedInlinkedin.com/company/aphriainc

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aphria Inc